![Stina Singel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stina Singel
Chief Tech/Sci/R&D Officer at
ASCENDIS PHARMA A/S
Net worth: - $ as of 2026-05-30
Profile
Currently, Stina Singel is Executive VP & Head-Clinical Development at Ascendis Pharma A since 2023.
Formerly, Dr. Singel was SVP, Head-Clinical Development & Drug Safety at Nektar Therapeutics from 2019 to 2020 and Senior Medical Director at Genentech, Inc. from 2014 to 2019.
Education includes a doctorate from The Salk Institute for Biological Studies, an undergraduate degree from Harvard University, and a doctorate from the University of California San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASCENDIS PHARMA A/S -.--% | 2025-12-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Stina Singel active positions
| Companies | Position | Start |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 2020-04-30 |
Former positions of Stina Singel
| Companies | Position | End |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 2020-04-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | 2019-03-31 |
Training of Stina Singel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
The Salk Institute for Biological Studies
 The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
- Stock Market
- Insiders
- Stina Singel
